Colorectal Cancer

New clinical trials open doors for positive changes in treatment of colorectal cancer.

A new technology that can detect small amounts of circulating tumor DNA in the blood of patients who previously received a diagnosis of certain types of cancer may dramatically accelerate the ability to cure more patients, says an expert from the University of Texas MD Anderson Cancer Center.

The identification of rare genomic alterations in patients with colorectal cancer gives oncologists the opportunity to treat patients who otherwise might not have many options.

As the incidence of GI cancer creeps up among younger patients, so does the question of why.

In honor of Colorectal Cancer Awareness Month, CURE® compiled some recent colorectal cancer news and updates patients and survivors may have missed.

March is National Colorectal Cancer Awareness Month and national leading nonprofit the Colorectal Cancer Alliance launched a new “Pledge To Get Screened” campaign – a public health initiative urging every American to join together to make a difference to combat colorectal cancer by pledging to get their recommended cancer screenings.

From a childhood cancer survivor being named a member of the first all-civilian SpaceX mission to colorectal cancer survivors golfing alongside PGA Tour champions in the Cologuard Classic, here’s what’s happening in the cancer space this week.

Sending a text message reminder to participants about their upcoming fecal immunochemical test improved previously poor adherence rates for colorectal cancer screening.

Danielle Ripley-Burgess, a two-time colon cancer survivor, discusses why she wrote a book about her journey and how her experience strengthened her faith.

While aspirin has been shown to be a protective factor against colorectal cancer in younger adults, recent findings show that the benefit is nonexistent in individuals over the age of 70.

Patients with rectal cancer who maintain a clinical complete response – meaning they are found to have no evidence of disease – after three years, may not need as frequent surveillance after that point, due to a decreased chance of regrowth and metastases.

In the final analysis of the phase 2 TASCO1 trial, patients within the Lonsurf and Avastin arm reached a median overall survival of 22.31 months compared with 17.67 months in the Xeloda and Avastin arm.

The researchers concluded that the overall low health-related quality of life scores for young CRC survivors in the categories of social and functional well-being should be targeted by appropriate methods, which could include counseling and quality of life interventions.

Several studies have identified an increased risk of colorectal cancer (CRC) among those suffering from a chronic condition such as Crohn’s disease, diabetes, or obesity. Interestingly, this association is particularly evident among millennials, meaning those who were in the 22-37 age group between 2014 and 2018.

Aside from the physical challenges associated with colorectal cancer, managing the many health administrative aspects of a chronic disease is an added burden to the lives of patients and their caregivers.

A shared decision-making tool is an approach that allows the clinician to collaborate with the patient in reaching evidence-informed decision making.

National guidelines recommend initial surveillance colonoscopy one year after colorectal cancer surgery, but only 57.5% of patients received one in this study due to racial disparities.

As we enter the holiday season, we know that quality time spent connecting with family is upon us. Even if your gatherings are virtual this year, we encourage you to bring up your family medical history and support each other in understanding your family’s risk factors for colorectal cancer.

For one cancer survivor, laughter might have been the best medicine.

Watch our metastatic colorectal cancer webinar where an expert panel discussed topics highly relevant to nurses as they care for patients and provide support to caregivers.

From actor Jason Momoa gifting a trident to a young fan of the superhero movie “Aquaman” who is receiving treatment for an aggressive form of brain cancer, to data demonstrating the regular consumption of chili peppers is associated with lower cancer mortality rates, here’s everything happening in the cancer landscape this week.

The Colorectal Cancer Alliance (Alliance) today announced $500,000 in total funding for two colorectal cancer (CRC) studies through its Chris4Life Research Program.

Watch our first colorectal cancer webinar where an expert panel discussed topics highly relevant to patients, caregivers and advocates.

From AstraZeneca announcing that it’s blood cancer drug Calquence is not effective for patients with COVID-19 to a street artist using a lab pipette to create a painting representing cancer out of 50,000 dots of paint, here’s what’s happening in the cancer landscape this week.

Findings from this analysis determined that diet may not affect survival, which may lead to a stronger focus on exercise at the start of first-line treatment for metastatic disease.

The anticipated draft recommendation from the U.S. Preventive Task Force Services (USPSTF) is here…and it brought forth great news for the colorectal cancer (CRC) community. This independent panel of experts has proposed lowering CRC screening age for average-risk adults from 50 to 45 years.